Serum alkaline phosphatase and 30-day mortality after surgery for spinal metastatic disease.
Aditya V KarhadeQuirina C B S ThioPaul T OginkJoseph H SchwabPublished in: Journal of neuro-oncology (2018)
Elevated preoperative serum alkaline phosphatase is a marker for 30-day mortality in patients undergoing surgery for spinal metastatic disease. Future retrospective and prospective study designs should incorporate assessment of this serum biomarker to better understand the role for serum alkaline phosphatase in improving prognostication in spinal metastatic disease.